Clinical Trials on Prostatic Neoplasms
Total 107211 results
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)TerminatedStage I Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
ProteoMediX AGCompletedIndication for Prostate Biopsy Due to Suspected Prostate CancerAustria, Germany, Denmark
-
National Cancer Institute (NCI)CompletedProstate Neoplasms | Prostate Specific AntigensUnited States
-
Northwestern UniversityRecruitingMetastatic Prostate Carcinoma | Recurrent Prostate Carcinoma | Stage IV Prostate Cancer | Hormone-Refractory Prostate Cancer | Castration-Resistant Prostatic CancerUnited States
-
Dana-Farber Cancer InstituteEpizyme, Inc.; PfizerRecruitingMetastatic Prostate Cancer | Metastatic Castration-resistant Prostate CancerUnited States
-
Azienda Socio Sanitaria Territoriale degli Spedali...TakedaUnknownIntermediate Risk Prostate Cancer | High Risk Prostate CancerItaly
-
National Cancer Institute (NCI)TerminatedAdenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Bone Metastases | Hormone-resistant Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate Cancer | Soft Tissue MetastasesUnited States
-
Rennes University HospitalCompletedBenign Prostate HyperplasiaFrance
-
Ohio State University Comprehensive Cancer CenterRiverside Methodist HospitalCompletedStage I Prostate Cancer | Stage III Prostate Cancer | Stage IV Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedStage III Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate Cancer | Stage IIB Prostate CancerUnited States
-
National Cancer Institute (NCI)CompletedProstate Adenocarcinoma | Recurrent Prostate Carcinoma | Stage IV Prostate Cancer | Hormone-Resistant Prostate CancerUnited States
-
Mayo ClinicRecruitingPrimary Malignant Neoplasm of Prostate (Diagnosis)United States
-
Jiangsu HengRui Medicine Co., Ltd.RecruitingCastration-Resistant Prostate CancerChina
-
Jiangnan UniversityAffiliated Hospital of Jiangnan UniversityRecruitingCastration-resistant Prostate CancerChina
-
Azienda Ospedaliera Città della Salute e della...KoelisRecruiting
-
Technical University of MunichRecruitingCastration-resistant Prostate CancerGermany
-
Northwestern UniversityNorthShore University HealthSystemCompletedProstate CancerUnited States
-
German Oncology Center, CyprusActive, not recruitingProstate Adenocarcinoma | Radiation ToxicityCyprus
-
Memorial Sloan Kettering Cancer CenterCelgene CorporationCompletedProstate Cancer | Castration Resistant Prostate CancerUnited States
-
University of MiamiCompletedProstate Cancer | Prostate Adenocarcinoma | Radiation ToxicityUnited States
-
Assistance Publique - Hôpitaux de ParisCompletedLow-Risk Prostate CancerFrance
-
Korean Cancer Study GroupCompletedHormone Refractory Prostate CancerKorea, Republic of
-
Donald Trump, MDTerminated
-
Celsee DiagnosticsWithdrawnMetastatic Prostate Cancer, CTC
-
Bavarian NordicCompletedAndrogen-insensitive Prostate CancerUnited States
-
Astellas Pharma Europe B.V.Medivation, Inc.CompletedProstate Cancer | Castration-Resistant Prostate CancerRussian Federation, Georgia
-
Daniel VaenaCompletedProstate Cancer | Castrate Resistant Prostate CancerUnited States
-
Zealand University HospitalUniversity Hospital Schleswig-HolsteinUnknownHormone-refractory Prostate CancerDenmark, Germany
-
Eli Lilly and CompanyCompletedAdenocarcinoma of the ProstateUnited States
-
Dana-Farber Cancer InstituteCompletedProstate Cancer | Adenocarcinoma of the ProstateUnited States
-
Sunnybrook Health Sciences CentreUnknownCarcinoma of the ProstateCanada
-
CureVacCompletedHormonal Refractory Prostate CancerGermany, Italy
-
Burzynski Research InstituteWithdrawnStage IV Prostate CancerUnited States
-
Tianjin Medical University Cancer Institute and...Peking University First Hospital; The Affiliated Nanjing Drum Tower Hospital... and other collaboratorsUnknownStage IV Prostate CancerChina
-
US Oncology ResearchEli Lilly and Company; Oregon Health and Science UniversityCompletedAndrogen-independent Prostate CancerUnited States
-
Mary-Ellen Taplin, MDSanofi; Beth Israel Deaconess Medical Center; Genentech, Inc.; Duke UniversityCompletedProstate Cancer | Adenocarcinoma of the ProstateUnited States
-
Temple UniversityCompleted
-
ExelixisTerminatedProstatic Neoplasms | Prostate Cancer | Castration Resistant Prostate CancerUnited States
-
Infinity Pharmaceuticals, Inc.CompletedProstatic Neoplasms | Prostate Cancer | Cancer of the ProstateUnited States
-
AgennixCompletedProstate Cancer | Hormone Refractory Prostate CancerUnited States, United Kingdom, France, Italy, Israel, Germany, Hungary, Argentina, Russian Federation, Belgium, Croatia, Netherlands, Peru, Poland, Spain
-
AstraZenecaCompletedNon-metastatic Prostate CancerUnited States, Canada
-
Veeda OncologyBayerTerminatedHormone Refractory Prostate CancerUnited States
-
Zhengzhou UniversityThe First Affiliated Hospital of Zhengzhou University; Xinyang Central Hospital and other collaboratorsUnknown
-
CytoVac A/SCompletedHormone-refractory Prostate CancerDenmark
-
University of FloridaCureVacTerminated
-
National University Hospital, SingaporeCompletedHormone-Refractory Prostate CancerSingapore
-
CytRxCompletedHormone Refractory Prostate CancerUnited States
-
AstraZenecaCompletedNon-Metastatic Prostate CancerCzech Republic, Italy, South Africa, United Kingdom, Germany, Poland, Netherlands, Austria, Belgium, Hungary, Israel, Portugal, Mexico, Spain, Australia, Ireland
-
Ascenta TherapeuticsCompletedHormone Refractory Prostate CancerUnited States, Russian Federation